The $1 billion deal emphasises that for IP professionals a detailed understanding of data-related issues is set to become essential
The rise of disruptive new technology means that everything you thought you knew about making money from IP is set to change
Services at the FDA could “grind to a halt” in a matter weeks if the budget deadlock between President Trump and Democrats continues. Major disruption at the USPTO and in the courts may also be on the cards.
IAM Market teams up with Richardson Oliver Insights to deliver new tranche of assets to its IP buying, selling, licensing and tech transfer platform being offered by top brokers
With the festive season now upon us, those looking for gift ideas can delve into the wonderful world of patents for inspiration.
This year's event in Shanghai has now come to an end. It's been a great couple of days, including the IP Asia Elite Gala Dinner and Awards held last night
How Chinese courts will rule the patent world; Qualcomm's 5G licensing spree; don't jail trolls, says former supreme court judge; patent sales are on the up; plus a whole lot more from a wet, but spectacular, Shanghai Pudong
Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one
The inside track on a 50-year exercise in managing a multi-dimensional value creation strategy that keeps on delivering successful results
In an exclusive opinion piece for IAM, Jim Beveridge of the Innovators' Network argues that originators need to embrace transparency and avoid royalty stacking to allow IoT innovation to thrive
After years of dictating the patent narrative in the US - and reaping the rewards - BigTech now finds itself on the back foot as it loses friends in the executive and Congress. Will the courts be next?
Qingdao metal manufacturer fended off ITC Section 337 complaint with fastidious R&D record keeping, among other factors
A new US NPE launches with bold claims about asserting in China. Its timing might prove problematic.
The boss of an NPE that launched in late June with $100 million of funding has said that within the next two weeks it will be filing “extremely large patent infringement lawsuits in China, against a major consumer products manufacturer”.